PIP-Implantate - Update

PIP-Implantate - Update

Logo der NHS-Website
Am 18.6.2012 hat eine Expertenkommission des britischen National Health Service (NHS) einen Abschlussbericht zum Thema PIP-Brustimplantate vorgelegt.
Näheres siehe unter:

Nachfolgend die Kernaussagen:

The expert group has found that:

-    Exhaustive worldwide testing of the PiP gel material has not revealed anything that could cause a long-term threat to human health – they are not toxic and not carcinogenic.

-    PiP implants do have a higher rupture rate – around 2 times higher. The rate of rupture appears to be around 6 to 12% after 5 years, rising to 15 to 30% after 10 years (this compares to 10 to 14% after 10 years for other brands of implants).

-    PiP implants have a higher concentration of certain compounds called siloxanes – chemically similar to silicone but of a lower molecular weight and found in many consumer products, including hair and skin care products, antiperspirants and deodorants – but this does not present a health risk.

-     Although the contents are not harmful and the gel has not been shown to contain any toxic substances, the inferior mechanical strength of the implants led the group to consider this a substandard product.

-     If the implant does rupture, it has been found to cause local reactions around the implant area in a small proportion of women, which can result in symptoms such as tenderness or swollen lymph glands. There is no evidence that this causes any more significant general health concern however.


PIP-Implantate sind nicht toxisch oder krebsauslösend, sie haben aber eine deutlich höhere Rupturrate.
Wenn die Implantathülle reißt, kann es zu lokalen Reaktionen im Bereich der Implantate mit Spannungsgefühl und Lymphknotenschwellung kommen.
erstellt: 10-05-2013 16:56
Geschrieben von Prof. Dr. med. Peter Graf